ESR1 and triple-negative breast carcinoma: Particularly in triple-negative breast cancer (TNBC), a subtype known for its high metastatic potential, PD-L1 upregulation has been linked to aggressive characteristics, such as advanced histological grade, the absence of estrogen receptor (ER) expression, and increased infiltration by regulatory T cells (Tregs) [9,10].